Inserm UMRS1162, Equipe Labellisée la Ligue Contre le Cancer, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, 75010, Paris, France.
School of Life Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.
Nat Commun. 2017 Dec 13;8(1):2103. doi: 10.1038/s41467-017-02282-w.
The c-myc oncogene stimulates ribosomal biogenesis and protein synthesis to promote cellular growth. However, the pathway by which cells sense and restore dysfunctional mRNA translation and how this is linked to cell proliferation and growth is not known. We here show that mRNA translation stress in cis triggered by the gly-ala repeat sequence of Epstein-Barr virus (EBV)-encoded EBNA1, results in PI3Kδ-dependent induction of E2F1 mRNA translation with the consequent activation of c-Myc and cell proliferation. Treatment with a specific PI3Kδ inhibitor Idelalisib (CAL-101) suppresses E2F1 and c-Myc levels and causes cell death in EBNA1-induced B cell lymphomas. Suppression of PI3Kδ prevents E2F1 activation also in non-EBV-infected cells. These data illustrate an mRNA translation stress-response pathway for E2F1 activation that is exploited by EBV to promote cell growth and proliferation, offering new strategies to treat EBV-carrying cancers.
c-myc 癌基因刺激核糖体生物发生和蛋白质合成,以促进细胞生长。然而,细胞感知和恢复功能失调的 mRNA 翻译的途径以及这与细胞增殖和生长的联系尚不清楚。我们在这里表明,由 Epstein-Barr 病毒(EBV)编码的 EBNA1 的甘-丙氨酸重复序列顺式触发的 mRNA 翻译应激,导致 PI3Kδ 依赖性 E2F1 mRNA 翻译的诱导,从而激活 c-Myc 和细胞增殖。用特异性 PI3Kδ 抑制剂 Idelalisib(CAL-101)处理可抑制 E2F1 和 c-Myc 水平,并导致 EBNA1 诱导的 B 细胞淋巴瘤中的细胞死亡。PI3Kδ 的抑制也可防止非 EBV 感染细胞中的 E2F1 激活。这些数据说明了 E2F1 激活的 mRNA 翻译应激反应途径,该途径被 EBV 利用来促进细胞生长和增殖,为治疗 EBV 携带的癌症提供了新策略。